Login Start for Free

My Subscriptions My Account My Orders Log Out

Overview
Financial Statements
KPIs & Operating Metrics
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Investments Non-Current Assets Non-Current Deffered Revenue Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Amortization of Deferred Charges Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Debt Issuances and Repayments Net Income Non-cash Items Other financing activities Share-based Compensation Shares Issued

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Price Price to Book Price to Earnings Price to Sales

Growth Metrics

EBIT Margin (QoQ)EBIT Margin Growth (1y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBT Margin (QoQ)EBT Margin Growth (1y)Enterprise Value (QoQ)Enterprise Value Growth (1y)FCF Margin (QoQ)FCF Margin Growth (1y)Gross Margin (QoQ)Gross Margin Growth (1y)Net Margin (QoQ)Net Margin Growth (1y)Operating Margin (QoQ)Operating Margin Growth (1y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Sales (QoQ)Return on Sales Growth (1y)

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Expense - Real Estate Gross Profit Income from Continuing Operations Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding (Weighted Average)Tax Provisions Tax Rate

Others

Expense - Property and Maintenance Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Gross Margin Invested Capital Market Capitalization Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales

NewAmsterdam Pharma Co N.V (NAMS) Net Margin (QoQ): 2023-2025

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount